TENON MEDICAL INC (TNON) Stock Analyst Earnings Estimates
NASDAQ:TNON - Nasdaq - US88066N3035 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 690K 331.25% | 2.928M 324.35% | 3.277M 11.92% | 4.556M 39.03% | 7.574M 66.24% | 11.902M 57.14% | 22.564M 89.58% | 36.451M 61.54% | 49.208M 35.00% | |
| EBITDA YoY % growth | -18.65M -188.70% | -15.301M 17.96% | -13.111M 14.31% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -18.73M -189.94% | -15.727M 16.03% | -13.766M 12.47% | -8.876M 35.52% | -13.556M -52.72% | -13.318M 1.75% | -6.908M 48.13% | -1.34M 80.60% | 7.353M 648.62% | |
| Operating Margin | -2,714.49% | -537.12% | -420.08% | -194.82% | -178.98% | -111.90% | -30.62% | -3.68% | 14.94% | |
| EPS YoY % growth | N/A | -77.92 59.71% | -24.33 68.78% | -2.00 91.76% | -0.97 51.65% | -0.66 31.58% | -0.31 53.85% | -0.05 83.33% | 0.20 500.00% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.48 94.13% | -0.44 87.78% | -0.38 85.14% |
| Revenue Q2Q % growth | 927.69K 2.96% | 1.297M 46.22% | 1.59M 106.49% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.62M 6.51% | -3.484M -8.36% | -3.477M -9.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -1.01 89.90% | -1.13 | 0.12 | 10.79% |
| Q4 2024 Q2Q % growth | -2.54 53.31% | -2.59 | 0.05 | 1.96% |
| Q3 2024 Q2Q % growth | -3.63 68.92% | -4.32 | 0.69 | 15.97% |
| Q2 2024 Q2Q % growth | -8.16 69.09% | -8.85 | 0.69 | 7.83% |
| Q1 2024 Q2Q % growth | -10.00 70.93% | -10.93 | 0.93 | 8.55% |
| Q4 2023 Q2Q % growth | -5.44 90.29% | -11.26 | 5.82 | 51.69% |
| Q3 2023 Q2Q % growth | -11.68 47.86% | -22.85 | 11.17 | 48.88% |
| Q2 2023 Q2Q % growth | -26.40 49.23% | -31.01 | 4.61 | 14.86% |
| Q1 2023 Q2Q % growth | -34.40 | -30.19 | -4.21 | -13.94% |
| Q4 2022 Q2Q % growth | -56.00 | -57.12 | 1.12 | 1.96% |
| Q3 2022 Q2Q % growth | -22.40 | -38.35 | 15.95 | 41.59% |
| Q2 2022 Q2Q % growth | -52.00 | -16.32 | -35.68 | -218.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 726K 0.97% | 1.223M | -497K | -40.64% |
| Q4 2024 Q2Q % growth | 770K -4.70% | 1.48M | -710K | -47.97% |
| Q3 2024 Q2Q % growth | 887K -6.04% | 1.214M | -327K | -26.94% |
| Q2 2024 Q2Q % growth | 901K 21.27% | 927.69K | -26.69K | -2.88% |
| Q1 2024 Q2Q % growth | 719K 66.05% | 798.66K | -79.66K | -9.97% |
| Q4 2023 Q2Q % growth | 808K 188.57% | 1.084M | -276K | -25.46% |
| Q3 2023 Q2Q % growth | 944K 349.52% | 1.093M | -149K | -13.63% |
| Q2 2023 Q2Q % growth | 743K 430.71% | 1.02M | -277K | -27.16% |
| Q1 2023 Q2Q % growth | 433K 518.57% | 467.16K | -34.16K | -7.31% |
| Q4 2022 Q2Q % growth | 280K 460.00% | 282.54K | -2.54K | -0.90% |
| Q3 2022 Q2Q % growth | 210K 200.00% | 289.68K | -79.68K | -27.51% |
| Q2 2022 Q2Q % growth | 140K 275.34% | 144.84K | -4.84K | -3.34% |
| Q4 2021 Q2Q % growth | 50K 400.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 61% | 26.27% | 44.28% |
| Revenue | 0% | -39.68% | -4.94% | -27.68% |